Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Emergent Biosolutions (NY: EBS )

9.120 +0.060 (+0.66%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Emergent Biosolutions

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
From Emergent BioSolutions
Via GlobeNewswire
Looking Into Emergent BioSolutions's Recent Short Interest
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper highlights five stocks each week that are seeing increased attention from readers and partners. 
Via Benzinga
Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?
Emergent reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of losses of 83 cents by 171.08%. 
Via Benzinga
Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results
Via Benzinga
Dow Surges Over 100 Points; ConocoPhillips Earnings Miss Views
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
MercadoLibre Stock Split: Will MELI Investors See Wishes Come True Today?
MercadoLibre stock is up on Thursday as investors are hoping a split for MELI shares will be announced after markets close today. 
Via InvestorPlace
JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock
Carvana stock is climbing higher on Thursday after shares of CVNA got an increased price target and upgrade from JPMorgan analyst Rajat Gupta. 
Via InvestorPlace
Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts
Emergent BioSolutions layoffs have the life sciences company cutting 300 jobs as it also plans to close down two of its facilities. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Nasdaq Jumps Over 100 Points; Kellanova Posts Upbeat Results
Via Benzinga
Why Is Freshworks (FRSH) Stock Down 17% Today?
Freshworks stock is falling on Thursday as FRSH investors learn of its CEO stepping down and react to lackluster 2024 guidance. 
Via InvestorPlace
Why Is Fastly (FSLY) Stock Down 36% Today?
Fastly stock is falling on Thursday as FSLY investors react to weak guidance and mixed results in its earnings report for Q1 2024. 
Via InvestorPlace
Why Is Carvana (CVNA) Stock Up 36% Today?
Carvana stock is up on Thursday after the company surprised CVNA investors with record profits and revenue during the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?
Emergent BioSolutions stock is up on Thursday after the life sciences company posted a surprising profit and strong earnings in Q1 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday! 
Via InvestorPlace
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
EBS earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
EBS Stock Earnings: Emergent BioSolutions Beats EPS, Beats Revenue for Q1 2024
EBS stock results show that Emergent BioSolutions beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Emergent BioSolutions Reports First Quarter 2024 Financial Results
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
From Emergent BioSolutions
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
From Emergent BioSolutions
Via GlobeNewswire
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
Appoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of Directors 
From Aquestive Therapeutics, Inc.
Via GlobeNewswire
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
From Emergent BioSolutions
Via GlobeNewswire
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.